Australian farmer launches legal action against Bayer over weedkiller: report
Reuters
Published Oct 10, 2019 06:43AM ET
Australian farmer launches legal action against Bayer over weedkiller: report
MELBOURNE (Reuters) - An Australian farmer has launched a legal case against Bayer (DE:BAYGN) AG's agricultural chemicals unit Monsanto (NYSE:MON) after being diagnosed with a type of leukaemia, the Australian Broadcasting Commission reported on Thursday.
New South Wales farmer Ross Wild was diagnosed with Hodgkin's Lymphoma last year after using the weedkiller Roundup on his farming property near the border of NSW and Victoria since 1976, ABC reported.
He claims that long-term exposure to Roundup's active ingredient, glyphosate, was to blame, ABC said.
Bayer did not have an immediate comment on the case.
He will be represented by managing partner Tony Carbone of Carbone Lawyers, according to the report. The firm did not did not immediately respond to an email requesting comment.
In June, Carbone Lawyers, acting for an Australian gardener, filed a lawsuit against Bayer for severe harm caused by a Roundup, the first such case in the country.
The lawsuit follows court rulings in the United States linking Roundup’s main ingredient, glyphosate, to cancer, which has already taken tens of billions of euros off Bayer’s market value.
For Bayer - inventor of Aspirin and maker of stroke prevention drug Xarelto and Yasmin birth control pills – lawsuits in the United States are the biggest headache with more than 13,400 plaintiffs bringing claims over the herbicide’s alleged cancer risk.
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.